Data from first patient cohort provide human proof-of-concept and support continued dose escalation in patients with small cell lung cancer and large cell neuroendocrine carcinoma Pharmacokinetic, dosimetry, and imaging data… Read More
Analysis of the FAERS database shows that the real-world abuse potential of the DORA class is very low and markedly less than those seen for other scheduled and non-scheduled insomnia… Read More
GSK supports seasonal flu immunization in Canada with domestic supply of Fluviral vaccine in advance of flu season MISSISSAUGA, ON – GSK Canada (GlaxoSmithKline Inc.) announced it has started shipping… Read More
Chemotherapy-free combination regimen ushers in new era for first-line treatment, with overall survival projected to exceed four years, surpassing monotherapy TKI osimertinib by more than one year RARITAN, N.J. – Johnson… Read More
Updated MARIPOSA analysis at WCLC shows combination prevents common EGFR and MET resistance, helping patients live longer Additional study results highlight strategies to reduce dermatologic reactions and simplify administration with once-monthly subcutaneous… Read More
